Drugs targeting TOP2 (TOP2 poisons) are important and effective anti-cancer agents, but they are associated with serious side effects including the development of therapy related acute leukemia (t-AL), especially acute myeloid leukemia (t-AML). Here, TOP2A is linked to acute leukemia.